Product Information
BUTENAFINE HCL 1% CREAM is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.3070 per GM under NDC 51672210002. Its NADAC has been published 181 times since Oct 20, 2021.
FDA first approved this application on Nov 16, 2017.
Strength
10 mg/g
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
51672210002
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
BUTENAFINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205181FDA Approved
11/16/2017
On Market Since
11/17/2017
Pharmacological Classes
Price Statistics
The NADAC for BUTENAFINE HCL 1% CREAM has been published 181 times since Oct 20, 2021, and over the history we have for it it has declined 2.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3070 per GM |
|---|---|
| All-time high | $0.3281 (Oct 15, 2025) |
| All-time low | $0.3036 (Apr 22, 2026) |
| 52-week high | $0.3281 |
| 52-week low | $0.3036 |
| Median price | $0.3152 |
| Average price | $0.3134 |
| Largest weekly change | +3.6% (Sep 17, 2025) |
| Weeks tracked | 181 |
| Tracking since | Oct 20, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Butenafine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BUTENAFINE HCL 1% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for BUTENAFINE HCL 1% CREAM, manufactured by Sun Pharmaceutical Industries Inc., is $0.3070 per GM (NDC 51672210002), effective Sep 30, 2026.
How has the price of BUTENAFINE HCL 1% CREAM changed over time?
Over the history we have for it, the NADAC for BUTENAFINE HCL 1% CREAM has declined 2.9%. It has been tracked across 181 weekly CMS publications since Oct 20, 2021.
What are the highest and lowest recorded NADAC prices for BUTENAFINE HCL 1% CREAM?
Since Oct 20, 2021, the NADAC for BUTENAFINE HCL 1% CREAM has ranged from a low of $0.3036 (Apr 22, 2026) to a high of $0.3281 (Oct 15, 2025), with a median of $0.3152 per GM.
Are there cheaper alternatives to BUTENAFINE HCL 1% CREAM?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BUTENAFINE HCL 1% CREAM in a comparable dosage form, but none are currently priced below it.
Who manufactures BUTENAFINE HCL 1% CREAM?
BUTENAFINE HCL 1% CREAM (NDC 51672210002) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.